Therapeutics, Inc.

Quick facts

Phase 2 pipeline

• Halobetasol Propionate Lotion 0.05%
• Halobetasol Proprionate Cream 0.05%
• Halobetasol Proprionate Lotion 0.05%
• UHE-101 Cream
• UHE-103A1 cream
• UHE-103A1B cream
• UHE-103A2 cream
• UHE-103A2B cream
• UHE-103B cream
• UHE-105

Phase 1 pipeline

• UHE-103 Cream

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Therapeutics, Inc. portfolio CI brief
• Therapeutics, Inc. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies